Browsing Tag
United States
338 posts
Texas gas station tragedy: How a Hyderabad student’s death exposes the risks behind global education dreams
A Hyderabad student was shot dead in Texas during a suspected gas station robbery. Find out what happened and why it’s reigniting debate on student safety abroad.
Trump eyes rare earth equity: Why Critical Metals (NASDAQ: CRML) stock is suddenly the hottest geopolitical bet
Critical Metals (NASDAQ: CRML) stock soars as Washington mulls an equity stake in Greenland’s Tanbreez rare earth project. Find out what’s behind the surge.
Australia’s $705m HIMARS bet: Smart defense move or risky dependence on U.S. systems?
Explore how the U.S. approved a $705M HIMARS sale to Australia, its implications for Indo-Pacific deterrence, alliance integration, and regional arms dynamics.
AOL’s surprising $1.4bn revival: Why Apollo is handing the internet pioneer to an Italian buyer
Yahoo is close to selling AOL to Italy’s Bending Spoons in a $1.4B deal. Find out what this means for Apollo, investors, and the future of legacy internet brands.
Williams bets $3.1bn on two power projects—Can a pipeline giant reinvent itself in clean energy?
Williams (NYSE: WMB) is spending $3.1B on two power projects with long-term PPAs, expanding its clean energy push—find out what it means for investors now.
Can Ancient + Brave’s B Corp collagen philosophy capture U.S. consumers in a crowded market?
Ancient + Brave launches in the U.S. with clinically backed collagen and supplements. Discover how this B Corp brand is reshaping wellness and longevity.
From water treatment to market consolidation: Why HASA’s acquisition of B’s Pool Supplies matters for the industry
HASA expands its California footprint with the acquisition of B’s Pool Supplies. Learn why this move strengthens its water treatment market leadership.
Pfizer just flipped the script on drug prices—now Eli Lilly and Amgen are ripping. Is this the start of a new pharma bull run?
Pfizer’s U.S. drug-pricing pact triggers a pharma relief rally. See what it means for Eli Lilly, Amgen, and investors today—read the data-driven outlook.
Can Conagra Brands inventory buildup offset the pain of tariffs and 7%+ inflation in 2025?
Conagra forecasts 7%+ inflation in 2025 and plans inventory buildup to boost supply resilience. Learn how it balances costs, margins, and growth.
From Nest Aware to Google Home Premium: How Alphabet is monetizing smart homes with AI
Explore how Google’s new Google Home Premium subscription transforms smart homes with Gemini AI — discover pricing, features & industry implications.